Abnormal Chondrocyte Apoptosis in the Cartilage Growth Plate is Influenced by Genetic Background and Deletion of CHOP in a Targeted Mouse Model of Pseudoachondroplasia
Pseudoachondroplasia (PSACH) is an autosomal dominant skeletal dysplasia caused by mutations in cartilage oligomeric matrix protein (COMP) and characterised by short limbed dwarfism and early onset osteoarthritis. Mouse models of PSACH show variable retention of mutant COMP in the ER of chondrocytes, however, in each case a different stress pathway is activated and the underlying disease mechanisms remain largely unknown. T585M COMP mutant mice are a model of moderate PSACH and demonstrate a mild ER stress response. Although mutant COMP is not retained in significant quantities within the ER of chondrocytes, both BiP and the pro-apoptotic ER stress-related transcription factor CHOP are mildly elevated, whilst bcl-2 levels are decreased, resulting in increased and spatially dysregulated chondrocyte apoptosis. To determine whether the abnormal chondrocyte apoptosis observed in the growth plate of mutant mice is CHOP-mediated, we bred T585M COMP mutant mice with CHOP-null mice to homozygosity, and analysed the resulting phenotype. Although abnormal apoptosis was alleviated in the resting zone following CHOP deletion, the mutant growth plates were generally more disorganised. Furthermore, the bone lengths of COMP mutant CHOP null mice were significantly shorter at 9 weeks of age when compared to the COMP mutant mice, including a significant difference in the skull length. Overall, these data demonstrate that CHOP-mediated apoptosis is an early event in the pathobiology of PSACH and suggest that the lack of CHOP, in conjunction with a COMP mutation, may lead to aggravation of the skeletal phenotype via a potentially synergistic effect on endochondral ossification.
References
[1]
Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, et al. (1995) Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in cartilage oligomeric matrix protein gene. Nature Genetics 10: 330–336. doi: 10.1038/ng0795-330
[2]
Di Cesare PE, Hauser N, Lehman D, Pasumarti S, Paulsson M (1994) Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 354: 237–240. doi: 10.1016/0014-5793(94)01134-6
[3]
McKeand J, Rotta J, Hecht JT (1996) Natural history study of pseudoachondroplasia. American Journal of Medical Genetics 63: 406–410. doi: 10.1002/(sici)1096-8628(19960517)63:2<406::aid-ajmg16>3.0.co;2-o
[4]
Chapman KL, Briggs MD (2003) Review: Clinical variability and genetic heterogeneity in multiple epiphyseal dysplasia. Pediatric Pathology and Molecular Medicine 22: 53–75. doi: 10.1080/15227950307699
[5]
Mann HH, Oezbek S, Engel J, Paulsson M, Wagener R (2004) Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem 279: 25294–25298. doi: 10.1074/jbc.m403778200
[6]
Holden P, Meadows RS, Chapman KL, Grant ME, Kadler KE, et al. (2001) Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem 276: 6046–6055. doi: 10.1074/jbc.m009507200
[7]
Halasz K, Kassner A, Morgelin M, Heinegard D (2007) COMP acts as a catalyst in collagen fibrillogenesis. Journal of Biological Chemistry 282: 31166–31173. doi: 10.1074/jbc.m705735200
[8]
Chen FH, Herndon ME, Patel N, Hecht JT, Tuan RS, et al. (2007) Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem 282: 24591–24598. doi: 10.1074/jbc.m611390200
[9]
Rock MJ, Holden P, Horton WA, Cohn DH (2010) Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and alphaVbeta3 integrin. Mol Cell Biochem 338: 215–224. doi: 10.1007/s11010-009-0355-3
[10]
Chen FH, Thomas AO, Hecht JT (2005) Cartilage oligomeric matrix protein/thrombonspondin-5 supports chondrocyte attachment through interaction with integrins. J Biol Chem 280: 32655–32661. doi: 10.1074/jbc.m504778200
[11]
Kennedy J, Jackson GC, Barker FS, Nundlall S, Bella J, et al. (2005) Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia – multiple epiphyseal dysplasia disease group. Hum Mutat 6: 593–594. doi: 10.1002/humu.9342
[12]
Delot E, King LM, Briggs MD, Wilcox WR, Cohn DH (1999) Trinucleotide expansion mutations in the cartilage oligomeric matrix protein (COMP) gene. Human Molecular Genetics 8: 123–128. doi: 10.1093/hmg/8.1.123
[13]
Hecht JT, Hayes E, Snuggs M, Decker G, Montufar-Solis D, et al. (2001) Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes. Matrix Biol 20: 251–262. doi: 10.1016/s0945-053x(01)00136-6
[14]
Suleman F, Gualeni B, Gregson H, Leighton M, Piróg K, et al. (2011) A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia. Human Mutation 33: 218–231. doi: 10.1002/humu.21631
[15]
Spitznagel L, Nitsche DP, Paulsson M, Maurer P, Zaucke F (2004) Characterization of a pseudoachondroplasia-associated mutation (His 587->Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP). Journal of Biochemistry 377: 479–487. doi: 10.1042/bj20031179
[16]
Pirog-Garcia KA, Meadows RS, Knowles L, Heinegard D, Thornton DJ, et al. (2007) Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP. Human Molecular Genetics 16: 2072–2088. doi: 10.1093/hmg/ddm155
[17]
Ron D, Habener J (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439–453. doi: 10.1101/gad.6.3.439
[18]
Wang X, Lawson B, Brewer J, Zinszner H, Sanjay A, et al. (1996) Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). Mol Cell Biol 16: 4273–4280.
[19]
Fornace AJ, Alamo IJ, Hollander M (1988) DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85: 8800–8804. doi: 10.1073/pnas.85.23.8800
[20]
Marciniak S, Yun C, Oyadomari S, Novoa I, Zhang Y, et al. (2004) CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18. doi: 10.1101/gad.1250704
[21]
McCullough K, Martindale J, Klotz L, Aw T, Holbrook N (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 21: 1249–1259. doi: 10.1128/mcb.21.4.1249-1259.2001
[22]
Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot R, et al. (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12: 982–995. doi: 10.1101/gad.12.7.982
[23]
Song B, Scheuner D, Ron D, Pennathur S, Kaufman R (2008) Chop deletion reduces oxidative stress, improves β cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest 118: 3378–3389. doi: 10.1172/jci34587
[24]
Chen R, Harrod K, Olson J, Gillespie M (2000) Regulation of gadd153 mRNA expression by hypoxia in pulmonary artery smooth muscle cells. Res Commun Mol Pathol Pharmacol 108: 3–14.
[25]
Averous J, Bruhat A, Jousse C, Carraro V, Thiel G, et al. (2004) Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation. J Biol Chem 279: 5288–5297. doi: 10.1074/jbc.m311862200
[26]
Ubeda M, Vallejo M, Habener J (1999) CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins. Mol Cell Biol 19: 7589–7599.
[27]
Dixon J, Dixon MJ (2004) Genetic Background Has a Major Effect on the Peentrance and Severity of Craniofacial Defects in Mice Heterozygous for the Gene Encoding the Nucleolar Protein Treacle. Developmental Dynamics 229: 907–914. doi: 10.1002/dvdy.20004
[28]
Gál I, Varga T, Szilágyi I, Balázs M, Schlammadinger J, et al. (2000) Protease-elicited TUNEL positivity of non-apoptotic fixed cells. Journal of Histochemistry and Cytochemistry 48: 963–970. doi: 10.1177/002215540004800709
[29]
Nundlall S, Rajpar H, Bell P, Clowes C, Zeeff LA, et al. (2010) An unfolded protein response is the initial cellular response to the expression of mutant matrilin-3 in a mouse model of multiple epiphyseal dysplasia. Cell Stress Chaperones 15: 835–849. doi: 10.1007/s12192-010-0193-y
[30]
Pham T, Piersma S, Warmoes M, Jimenez C (2010) On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics. Bioinformatics 26: 363–369. doi: 10.1093/bioinformatics/btp677
[31]
Pereira R, Standmeyer L, Marciniak S, Ron D, Canalis E (2006) C/EBP homologous protein is necessary for normal osteoblastic function. J Cell Biochem 97: 633–640. doi: 10.1002/jcb.20660
[32]
Briggs MD, Chapman KL (2002) Pseudoachondroplasia and Multiple Epiphyseal Dysplasia: Mutation Review, Molecular Interactions and Genotype to Phenotype Correlations. Human Mutation 19: 465–478. doi: 10.1002/humu.10066
Vranka J, Mokashi A, Keene DR, Tufa S, Corson G, et al. (2001) Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia. Matrix Biol 20: 439–450. doi: 10.1016/s0945-053x(01)00148-2
[35]
Hecht JT, Makitie O, Hayes E, Haynes R, Susic M, et al. (2004) Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate. J Orthop Res 22: 759–767. doi: 10.1016/j.orthres.2003.11.010
[36]
Schmitz M, Becker A, Schmitz A, Weirich C, Paulsson M, et al. (2006) Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion. J Biol Chem 281: 32587–32595. doi: 10.1074/jbc.m601976200
[37]
McLaughlin M, Karim S, Montague P, Barrie J, Kirkham D, et al. (2007) Genetic background influences UPR but not PLP processing in the rumpshaker model of PMD/SPG2. Neurochem Res 32: 167–176. doi: 10.1007/s11064-006-9122-y
[38]
Pereira R, Delany A, Canalis E (2004) CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology 145: 1952–1960. doi: 10.1210/en.2003-0868
[39]
Posey K, Veerisetty A, Liu P, Wang H, Poindexter B, et al. (2009) An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype. Am J Pathol 175: 1555–1563. doi: 10.2353/ajpath.2009.090184
[40]
Posey K, Coustry F, Veerisetty A, Liu P, Alcorn J, et al. (2012) Chop (Ddit3) is essential for D469del-COMP retention and cell death in chondrocytes in an inducible transgenic mouse model of pseudoachondroplasia. Am J Pathol 180: 727–737. doi: 10.1016/j.ajpath.2011.10.035
[41]
Moore K, Hollien J (2012) The unfolded protein response in secretory cell function. Annu Rev Gen doi: 10.1146/annurev-genet-110711-155644
[42]
Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, et al. (2006) Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLos Biol 4: e374. doi: 10.1371/journal.pbio.0040374
